Test results
| Appearance | Good · Pass |
|---|---|
| Identity | Confirmed · HPLC · Pass |
| Purity | 99.03% · HPLC · Spec ≥ 95.0% · Pass |
| Net peptide content | 120.65 mg · HPLC · Report only |
| Sterility | No Growth · PCR · Pass |
| Endotoxins | <0.05 EU/mL · LAL · Spec ≤ 5 EU/mL · Pass |
| Fentanyl screen | Not detected · Pass |
Batch details
| Product | MitoPrime (NAD+ / MOTs-C / 5-Amino-1MQ) |
|---|---|
| Batch / lot | NM002 |
| Certificate number | COA-2026-HYNDFT |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Jul 1, 2026 |
| Labeled amount | 120 |
| Method | 8X Testing |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to NM002. Every other batch of MitoPrime (NAD+ / MOTs-C / 5-Amino-1MQ) is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of MitoPrime (NAD+ / MOTs-C / 5-Amino-1MQ)
- Batch #33250, tested Mar 11, 2026